VAPO News and Press, Vapotherm Inc. From 02/23/23

The following slide deck was published by Vapotherm, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Vapotherm, Inc. 2022 Q4 - Results - Earnings Call Presentation

Vapotherm press release ( NYSE: VAPO ): Q4 GAAP EPS of -$0.78 in-line. Revenue of $18.7M (-15.8% Y/Y) beats by $0.84M . Fiscal Year 2022 Summary Total revenue for 2022 was $66.8 million Adjusted EBITDA was negative $12.0 million for the fourth quarter of ...

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced fourth quarter and fiscal year 2022 financial results. Fourth Quarter 2022 Summary Total revenue for the fourth quarter of 2022 was $18.7 million Gross margin was 27.5% in t...

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...

Global medical technology company, Vapotherm ( NYSE: VAPO ) has entered into a securities purchase agreement with investors through a private placement financing for gross proceeds of ~$23M. Pursuant to the agreement, the company agreed to issue 17.5M shares and pre-funded warrant...

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...

Summary Vapotherm has been struggling for years. The pandemic which appeared to be a blessing has not benefited the business at all; in fact, the contrary. The fundamental picture is too dire to become upbeat, even at these low levels. Shares remain unattractive in my book despi...

SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors follow...

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...